Align Technology | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
3M USD 4.46B 570M 2025-03
Align Technology USD 3.85B 92.37M 2024-12
Becton, Dickinson and Co. USD 25.2B 685M 2024-12
Bruker USD 1.8B 28M 2024-12
Cardinal Health USD -2991000000 286M 2024-12
Charles River Laboratories USD 3.46B 320.77M 2024-12
Cooper Companies USD 8.13B 44.1M 2025-01
CVS Health USD 75.56B 616M 2024-12
Danaher USD 50.85B 1.31B 2025-03
Dentsply International USD 1.94B 549M 2024-12
Dexcom USD 2.1B 123.6M 2024-12
Henry Schein USD 3.39B 110M 2024-12
Idexx Laboratories USD 1.6B 22.74M 2024-12
Insulet USD 1.21B 93.6M 2024-12
Integra LifeSciences USD 1.55B 23.69M 2024-12
IQVIA Holdings USD 6.07B 900M 2024-12
Masimo USD 1.05B 411.3M 2024-12
McKesson USD -3084000000 67M 2024-12
Mettler Toledo International USD -126890000 27.46M 2024-12
Revvity USD 7.67B 254.83M 2024-12
Solventum Corp 2.96B 233M 2024-12
Stryker USD 20.63B 485M 2024-12
Teleflex USD 4.28B 203.58M 2024-12
Thermo Fisher Scientific USD 49.36B 227M 2025-03
Veeva Systems USD 5.83B 330.97M 2025-01
Walgreens Boots Alliance USD 7.11B 2.83B 2025-02
Waters USD 1.83B 225.41M 2024-12
Zimmer Biomet Holdings USD 12.47B 93.4M 2024-12
Zoetis USD 4.77B 464M 2024-12



Align Technology Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.